Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib

Published:2014-09-16 Issue:22 Volume:20 Page:5686-5696
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Katayama Ryohei,Friboulet Luc,Koike Sumie,Lockerman Elizabeth L.,Khan Tahsin M.,Gainor Justin F.,Iafrate A. John,Takeuchi Kengo,Taiji Makoto,Okuno Yasushi,Fujita Naoya,Engelman Jeffrey A.,Shaw Alice T.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-silico QSAR Modeling for Identification of Novel Anticancer Agent as;PHYS CHEM RES;2024

2. Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy;Medicine in Drug Discovery;2024-09

3. A novel secondary ALK gene mutation which resistant to second-generation TKIs: a case report and literature review;Frontiers in Oncology;2024-08-29

4. Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer;Journal of the Formosan Medical Association;2024-08

5. Case report: Precise NGS and combined bevacizumab promote durable response in ALK-positive lung adenocarcinoma with multiple-line ALK-TKI resistance;Frontiers in Oncology;2024-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP